Retrospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 7, 2014; 20(37): 13538-13545
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13538
Figure 1
Figure 1 Different histological pictures after transarterial chemoembolization. A: A case of totally necrotic nodule (asterisk), with a well-visible fibrotic capsule (white arrow); B: A case of clear cell (CC) hepatocellular carcinoma with only partial necrosis (asterisk); C: Amicrovascular invasion. Haematoxylin-Eosin stain; Magnification × 2 (A) and × 10 (B, C).
Figure 2
Figure 2 Recurrence-free survival according to the three histological score classes. The actuarial recurrence-free survival rate is 96.7% in the low-risk group, 77.9% in the moderate-risk group and 40.0% in group the high-risk group.